Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerActivated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated ProteinsNeoplasia: the second decade.The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cellsCD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors.Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability.p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.The role of miR-200a in mammalian epithelial cell transformation.BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cellsCaveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancerRAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway.The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.The War on Cancer rages on.Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling.Ouabain-induced alterations of the apical junctional complex involve α1 and β1 Na,K-ATPase downregulation and ERK1/2 activation independent of caveolae in colorectal cancer cells.Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling.ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells.Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells.Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression.Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells.Cell-Based Assays to Study ERK Pathway/Caveolin1 Interactions.Reversal of the Migratory and Invasive Phenotype of Ras-Transfected Mammary Cells by Photodynamic Therapy Treatment.Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation
P2860
Q24628746-55252D75-6FDA-4869-B53F-D39938B08461Q27027458-97A38A8E-4C2C-4849-A8AF-72ED1F41C18EQ30484000-A0940BB6-A94B-44B9-A8D0-428F0D4590B4Q33676246-FF5F5F10-6B4C-4AB7-A2F7-42DE47B55324Q33711342-5EC996FF-F8E1-4209-875B-EB89B452158AQ33714946-74FF11BC-1FBF-446C-A4E1-2659E32909FBQ33759086-F6156EC8-5ACB-4AE4-AF8B-543DA7E0DC4BQ34712604-90BEC616-85B5-4385-ADE4-7DE56617C36AQ34917932-92D5DFA0-E1E5-4715-B0E6-38E54DE8C625Q35299011-486477AE-D1EF-4A2D-BD35-AFC6F03A81A4Q35349515-CCCAB3D6-FB56-4EBF-A136-C73FBC00A5CBQ35694314-7126FD6E-5BFB-4CDB-A559-3FA325355D6DQ35710117-3D8A98C7-E064-45AF-B455-5F3EA0125004Q37061758-7DE4BDE3-7CD4-4FA7-A7C8-6B290B75E3A1Q37259888-6421C62E-1FAD-4F29-AE0E-43F931B6E393Q37399283-C809187E-4BE3-414A-95B2-AE5CFE16CF0EQ37467189-14809B3A-1079-4E32-94F5-FE8C80179F28Q37478602-F61E0806-586F-41B9-AA62-CD644091E2BEQ38794213-0F007FE2-5D9E-4CDD-BC4A-F64DDECE36CFQ39067476-734ACDA4-D971-4FA5-9763-8FE34E364F3FQ39351108-C027CB1F-2F48-4949-884E-E77F8213B966Q39414588-46ACB0EC-3571-4100-9938-4053FA50E316Q39817737-A3B72780-3691-4249-925F-6E67929AFEFCQ41055307-E2F5E0FF-F2C2-4C34-AC1F-D7066D63B252Q43273315-FF893E16-C989-4096-BDF9-062F46E6D520Q50471650-BF322CBE-9CD2-4171-B2C6-A0FE2848C6FBQ51628923-14254C0B-881B-4FEF-9EB1-8F5C092D0C37Q55256814-653AEE13-21C7-4AE4-BE07-2758CF97A6F9Q58721369-61D9FDB5-DE69-4EEA-A6E6-789B00E43E02
P2860
Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@ast
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@en
type
label
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@ast
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@en
prefLabel
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@ast
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@en
P2860
P356
P1433
P1476
Restoration of E-cadherin cell ...... ormed breast epithelial cells.
@en
P2093
Quanwen Li
Raymond R Mattingly
P2860
P304
P356
10.1593/NEO.08968
P577
2008-12-01T00:00:00Z